fabrazyme.com - Fabrazyme® (agalsidase beta) ERT Treatment for Fabry Disease

home > domains > fabrazyme.com

Description: Discover Fabrazyme® (agalsidase beta), the only ERT (enzyme replacement therapy) indicated for patients 2 years and older with Fabry disease. See website for Important Safety Information & Full Prescribing Information including Boxed WARNING.

Example domain paragraphs

FOR U.S. RESIDENTS ONLY

The only ERT indicated for patients 2 years of age and older that has proven long-term efficacy and safety.

INDICATION AND USAGE

Links to fabrazyme.com (7)

• alprolixpro.com Hemophilia B coagulation Factor IX concentrate for adults and children | ALPROLIX® Professional
• fabry.org FSIG – Fabry Support & Information Group
• altuviiiohcp.com ALTUVIIIO® Homepage | Sanofi | for US HCPs
• rethinkrsv.com Beyfortus® (nirsevimab-alip) for RSV | For US HCPs | Sanofi Campus US
• lysosomaltreatmentcenter.com Home
• beyondtroughs.net It’s time to look at the bigger picture in hemophilia B | HCP Site
• avalideavapro.com Exploring Our Prescription Product Information | Sanofi USA